Ads
related to: sanofi- Dosing & Titration
Get Appropriate Dosing
for Patients. Learn More.
- Patient Brochure
Get Resources for Patients
Interested in this T2D Treatment
- Coverage Calculator
Check to See if Your
Patient is Covered for Treatment
- Co-Pay Card
Cost Savings for Eligible Patients.
Learn More.
- Dosing & Titration
Search results
The secrets of success with Paul Hudson, CEO of Sanofi, the leader who’s channeling AI to find the...
Fortune via AOL· 13 hours agoWe look into the lives, minds and agendas of CEOs at the world's most iconic companies. Paul Hudson,...
Cwm LLC Has $6.44 Million Stock Position in Sanofi (NASDAQ:SNY)
ETF DAILY NEWS· 11 hours agoCwm LLC trimmed its holdings in shares of Sanofi (NASDAQ:SNY – Free Report) by 1.7% during the 1st quarter, according to its most recent disclosure with the Securities and ...
Sanofi heads out to surf Belharra in $700M biobucks immunology deal
FierceBiotech· 2 days agoSanofi is offering Belharra Therapeutics up to $700 million in biobucks for a tow out to surf the...
Sanofi and Belharra forge $700m partnership for immunological diseases
Pharmaceutical Technology via Yahoo Finance· 2 days agoBelharra Therapeutics has announced that it has entered a strategic partnership with global...
9,852 Shares in Sanofi (NASDAQ:SNY) Acquired by V Square Quantitative Management LLC
ETF DAILY NEWS· 5 days agoV Square Quantitative Management LLC purchased a new position in Sanofi (NASDAQ:SNY – Free Report) during the 4th quarter, HoldingsChannel reports. The institutional investor ...
Fisher Asset Management LLC Lowers Stock Holdings in Sanofi (NASDAQ:SNY)
ETF DAILY NEWS· 3 days agoFisher Asset Management LLC lessened its stake in shares of Sanofi (NASDAQ:SNY – Free Report) by 4.4% in the 4th quarter, according to its most recent disclosure with the ...
3 Prominent Euronext Paris Dividend Stocks Offering Up To 8.1% Yield
Simply Wall St. via Yahoo Finance· 11 hours agoAmidst a backdrop of political uncertainty and fluctuating market indices in France, investors are...
Industry groups back drugmakers' appeal in Zantac cancer lawsuits
Reuters via Yahoo News· 2 hours agoGSK, Pfizer, Sanofi and Boehringer Ingelheim, which all sold Zantac at times, had asked Judge Vivian...
A Surprise Big Name Enters The Weight-Loss Melee
Investor's Business Daily· 6 days agoEvercore ISI analyst Umer Raffat said Gilead Sciences (GILD) hasn't been hyping the potential rival to Eli Lilly (LLY) and Structure Therapeutics (GPCR)....
Sanofi’s Xyzal partners with Sea.Hear.Now music festival in Asbury Park
NJBIZ· 7 days agoSanofi Consumer Healthcare-owned Xyzal is teaming up with iconic Asbury Park music festival...
